-
我が国のワクチン発祥の地、
長崎から新たに始まるワクチン開発研究
Topics
新着情報
-
感染症疫学短期コース “Introduction to Infectious Disease Epidemiology and Modelling” を開催しました
Thursday 24 August 2023
-
感染症疫学短期コース “Introduction to Infectious Disease Epidemiology and Modelling” を開催しました
Thursday 24 August 2023
登録されている記事がありません。
About us
ワクチン研究開発拠点について
長崎大学感染症研究出島特区 ワクチン研究開発拠点は,「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」に採択された4つのシナジー拠点の一つです。長崎大学がこれまで研究してきた高病原性病原体や熱帯性病原体を対象としたワクチン開発を推進し,人類の脅威となる感染症に対するワクチン開発を目指します。
Careers
公募・求人情報
-
現在募集中の公募・求人情報はありません。
Publications
研究業績
12924226
1
apa
5
default
desc
year
1
54
https://dida.nagasaki-u.ac.jp/dida_wp/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22HUUSSIZM%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mogasale%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMogasale%2C%20V.%20V.%2C%20Sinha%2C%20A.%2C%20John%2C%20J.%2C%20Hasan%20Farooqui%2C%20H.%2C%20Ray%2C%20A.%2C%20Chantler%2C%20T.%2C%20Mogasale%2C%20V.%2C%20Dhoubhadel%2C%20B.%20G.%2C%20Edmunds%2C%20W.%20J.%2C%20Clark%2C%20A.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282024%29.%20Research%20priorities%20to%20support%20typhoid%20conjugate%20vaccine%20decision-making%20in%20India%3A%20evidence%20assessment%20and%20stakeholder%20survey.%20%3Ci%3EBMJ%20Public%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E2%3C%5C%2Fi%3E%282%29%2C%20e001089.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjph-2024-001089%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjph-2024-001089%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Research%20priorities%20to%20support%20typhoid%20conjugate%20vaccine%20decision-making%20in%20India%3A%20evidence%20assessment%20and%20stakeholder%20survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijayalaxmi%20V%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anish%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22John%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Habib%22%2C%22lastName%22%3A%22Hasan%20Farooqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arindam%22%2C%22lastName%22%3A%22Ray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracey%22%2C%22lastName%22%3A%22Chantler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vittal%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhim%20Gopal%22%2C%22lastName%22%3A%22Dhoubhadel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W%20John%22%2C%22lastName%22%3A%22Edmunds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%5D%2C%22abstractNote%22%3A%22Background%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20India%20has%20a%20high%20typhoid%20fever%20burden.%20In%202022%2C%20the%20National%20Technical%20Advisory%20Group%20on%20Immunisation%20recommended%20introducing%20typhoid%20conjugate%20vaccine%20%28TCV%29%20into%20the%20Universal%20Immunisation%20Programme.%20Our%20study%20aims%20to%20identify%20research%20priorities%20to%20support%20ongoing%20TCV%20decision-making%20in%20India.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Methods%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20identified%2045%20evidence%20factors%20for%20TCV%20decision-making%20in%20India%20by%20adapting%20WHO%5Cu2019s%20Evidence-to-Recommendation%20framework.%20We%20assigned%20an%20evidence%20gap%20score%20for%20each%20evidence%20factor%20from%200%20%28low%29%20to%204%20%28high%29%20based%20on%20the%20availability%20and%20sufficiency%2C%20quality%2C%20breadth%20and%20applicability%20of%20evidence%20identified%20in%20a%20literature%20review%20%28end%20date%2030%20November%202023%29.%20We%20assigned%20each%20evidence%20factor%20an%20importance%20score%20based%20on%20the%20results%20of%20an%20online%20survey%20conducted%20among%20national%20immunisation%20stakeholders%20%28n%3D22%2C%201%20July%202023%5Cu201331%20October%202023%29%2C%20where%20they%20ranked%20the%20importance%20of%20seven%20WHO%5Cu2019s%20Evidence-to-Recommendation%20criteria%20and%20several%20evidence%20factors%20within%20them.%20We%20rescaled%20mean%20stakeholder%20rankings%20into%20importance%20scores%20from%200%20%28low%29%20to%204%20%28high%29.%20Finally%2C%20we%20added%20the%20evidence%20gap%20score%20to%20the%20importance%20score%20and%20used%20the%20overall%20scores%20to%20identify%20research%20priorities%20to%20support%20ongoing%20TCV%20decision-making%20in%20India.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Results%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20We%20estimated%20the%20highest%20evidence%20priority%20scores%20for%20public%20perception%20of%20typhoid%20fever%2C%20vaccination%20budget%20impact%2C%20vaccine%20availability%2C%20socioeconomic%20impact%2C%20fiscal%20space%2C%20antimicrobial%20resistance%20tracking%2C%20typhoid%20fever%20mortality%2C%20public%20perception%20of%20TCV%2C%20immunisation%20managers%5Cu2019%20acceptance%20and%20vaccine%20schedule%20preferences%20among%20caregivers.%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20Conclusion%20%5Cn%20%20%20%20%20%20%20%20%20%20%20%20%20%20By%20adapting%20WHO%5Cu2019s%20Evidence-to-Recommendation%20framework%20to%20the%20Indian%20context%2C%20we%20systematically%20identified%20several%20research%20priorities%20to%20support%20ongoing%20decision-making%20on%20TCV%20in%20India.%20These%20priorities%20will%20evolve%20as%20new%20research%20studies%20and%20questions%20emerge%20about%20the%20optimal%20scheduling%2C%20roll-out%20and%20implementation%20of%20TCV%20in%20India.%22%2C%22date%22%3A%2210%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjph-2024-001089%22%2C%22ISSN%22%3A%222753-4294%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fbmjpublichealth.bmj.com%5C%2Flookup%5C%2Fdoi%5C%2F10.1136%5C%2Fbmjph-2024-001089%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-12-11T04%3A14%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22DWRYRNR4%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mogasale%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMogasale%2C%20V.%20V.%2C%20Sinha%2C%20A.%2C%20John%2C%20J.%2C%20Hasan%20Farooqui%2C%20H.%2C%20Ray%2C%20A.%2C%20Chantler%2C%20T.%2C%20Mogasale%2C%20V.%2C%20Gopal%20Dhoubhadel%2C%20B.%2C%20John%20Edmunds%2C%20W.%2C%20Clark%2C%20A.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282024%29.%20Typhoid%20conjugate%20vaccine%20implementation%20in%20India%3A%20A%20review%20of%20supportive%20evidence.%20%3Ci%3EVaccine%3A%20X%3C%5C%2Fi%3E%2C%20%3Ci%3E21%3C%5C%2Fi%3E%2C%20100568.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvacx.2024.100568%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jvacx.2024.100568%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Typhoid%20conjugate%20vaccine%20implementation%20in%20India%3A%20A%20review%20of%20supportive%20evidence%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijayalaxmi%20V.%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anish%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22John%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Habib%22%2C%22lastName%22%3A%22Hasan%20Farooqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arindam%22%2C%22lastName%22%3A%22Ray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracey%22%2C%22lastName%22%3A%22Chantler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vittal%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhim%22%2C%22lastName%22%3A%22Gopal%20Dhoubhadel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W%22%2C%22lastName%22%3A%22John%20Edmunds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jvacx.2024.100568%22%2C%22ISSN%22%3A%2225901362%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2590136224001414%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-11-01T00%3A18%3A26Z%22%7D%7D%2C%7B%22key%22%3A%225ALYNPYU%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shrestha%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EShrestha%2C%20S.%2C%20Bajracharya%2C%20M.%2C%20Rimal%2C%20S.%2C%20Bhujel%2C%20R.%2C%20Chalise%2C%20B.%2C%20Basaula%2C%20Y.%20N.%2C%20Amatya%2C%20P.%2C%20Pandey%2C%20S.%2C%20Joshi%2C%20P.%2C%20Adhikari%2C%20N.%2C%20Ngwe%20Tun%2C%20M.%20M.%2C%20Morita%2C%20K.%2C%20Dumre%2C%20S.%20P.%2C%20%26amp%3B%20Pandey%2C%20B.%20D.%20%282024%29.%20A%20challenge%20to%20clinical%20management%3A%20A%20case%20of%20expanded%20dengue%20syndrome%20co-infection%20with%20dengue%201%20and%20dengue%203%20serotypes%20in%20Nepal.%20%3Ci%3EMedical%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E8%3C%5C%2Fi%3E%2C%20100123.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.hmedic.2024.100123%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.hmedic.2024.100123%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20challenge%20to%20clinical%20management%3A%20A%20case%20of%20expanded%20dengue%20syndrome%20co-infection%20with%20dengue%201%20and%20dengue%203%20serotypes%20in%20Nepal%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabin%22%2C%22lastName%22%3A%22Shrestha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milan%22%2C%22lastName%22%3A%22Bajracharya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandesh%22%2C%22lastName%22%3A%22Rimal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajshree%22%2C%22lastName%22%3A%22Bhujel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bimal%22%2C%22lastName%22%3A%22Chalise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuba%20Nidhi%22%2C%22lastName%22%3A%22Basaula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Prasanna%22%2C%22lastName%22%3A%22Amatya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shrijana%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pratik%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nabaraj%22%2C%22lastName%22%3A%22Adhikari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%20Prakash%22%2C%22lastName%22%3A%22Dumre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basu%20Dev%22%2C%22lastName%22%3A%22Pandey%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212%5C%2F2024%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.hmedic.2024.100123%22%2C%22ISSN%22%3A%2229499186%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS2949918624000883%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-11-01T00%3A15%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22TB94UZFU%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maure%20et%20al.%22%2C%22parsedDate%22%3A%222024-12-02%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMaure%2C%20C.%2C%20Khazhidinov%2C%20K.%2C%20Kang%2C%20H.%2C%20Auzenbergs%2C%20M.%2C%20Moyersoen%2C%20P.%2C%20Abbas%2C%20K.%2C%20Santos%2C%20G.%20M.%20L.%2C%20Medina%2C%20L.%20M.%20H.%2C%20Wartel%2C%20T.%20A.%2C%20Kim%2C%20J.%20H.%2C%20Clemens%2C%20J.%2C%20%26amp%3B%20Sahastrabuddhe%2C%20S.%20%282024%29.%20Chikungunya%20vaccine%20development%2C%20challenges%2C%20and%20pathway%20toward%20public%20health%20impact.%20%3Ci%3EVaccine%3C%5C%2Fi%3E%2C%20%3Ci%3E42%3C%5C%2Fi%3E%2826%29%2C%20126483.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.vaccine.2024.126483%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.vaccine.2024.126483%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chikungunya%20vaccine%20development%2C%20challenges%2C%20and%20pathway%20toward%20public%20health%20impact%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22Maure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kanat%22%2C%22lastName%22%3A%22Khazhidinov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hyolim%22%2C%22lastName%22%3A%22Kang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Auzenbergs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascaline%22%2C%22lastName%22%3A%22Moyersoen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gustavo%20Mendes%20Lima%22%2C%22lastName%22%3A%22Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Libia%20Milena%20Hernandez%22%2C%22lastName%22%3A%22Medina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20Anh%22%2C%22lastName%22%3A%22Wartel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerome%20H.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Clemens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sushant%22%2C%22lastName%22%3A%22Sahastrabuddhe%22%7D%5D%2C%22abstractNote%22%3A%22Chikungunya%20is%20a%20neglected%20tropical%20disease%20of%20growing%20public%20health%20concern%20with%20outbreaks%20in%20more%20than%20114%20countries%20in%20Asia%2C%20Africa%2C%20Americas%2C%20Europe%2C%20and%20Oceania%20since%202004.%20There%20are%20no%20specific%20antiviral%20treatment%20options%20for%20chikungunya%20virus%20infection.%20This%20article%20describes%20the%20chikungunya%20vaccine%20pipeline%20and%20assesses%20the%20challenges%20in%20the%20path%20to%20licensure%2C%20access%2C%20and%20uptake%20of%20chikungunya%20vaccines%20in%20populations%20at%20risk.%20Ixchiq%20%28VLA1533%5C%2FIxchiq%20%5Cu2013%20Valneva%29%20was%20the%20first%20licensed%20chikungunya%20vaccine%20by%20the%20US%20Food%20and%20Drug%20Administration%20in%20November%202023%2C%20European%20Medicines%20Agency%20in%20May%202024%2C%20and%20Health%20Canada%20in%20June%202024.%20Five%20chikungunya%20vaccine%20candidates%20%28BBV87%20%5Cu2013%20BBIL%5C%2FIVI%2C%20MV-CHIK%20%5Cu2013%20Themis%20Bioscience%2C%20ChAdOx1%20Chik%20%5Cu2013%20University%20of%20Oxford%2C%20PXVX0317%20%5C%2F%20VRC-CHKVLP059%5Cu201300-VP%20%5Cu2013%20Bavarian%20Nordic%2C%20and%20mRNA-1388%20%5Cu2013%20Moderna%29%20are%20in%20development.%20Evidence%20on%20chikungunya%20disease%20burden%20alongside%20the%20public%20health%20and%20economic%20impact%20of%20vaccination%20are%20critical%20for%20decision-making%20on%20chikungunya%20vaccine%20introduction%20in%20endemic%20and%20epidemic%20settings.%20Further%2C%20global%20and%20regional%20stakeholders%20need%20to%20agree%20on%20a%20sustainable%20financing%20mechanism%20for%20manufacturing%20at%20scale%20to%20facilitate%20fair%20access%20and%20equitable%20vaccine%20distribution%20to%20at-risk%20populations%20in%20different%20geographic%20settings.%20This%20could%20partly%20be%20facilitated%20through%20obtaining%20consensus%20on%20scientific%20and%20regulatory%20principles%20for%20initial%20vaccine%20introduction%20and%20generating%20evidence%20on%20chikungunya%20burden%20and%20disease%20awareness%20among%20populations%20at%20risk.%20Specifically%2C%20this%20article%20advocates%20for%20the%20formation%20of%20a%20global%20chikungunya%20vaccine%20consortium%20that%20includes%20regulators%2C%20policymakers%2C%20sponsors%2C%20and%20manufacturers%20to%20assist%20in%20overcoming%20the%20global%20and%20local%20challenges%20for%20chikungunya%20vaccine%20licensure%2C%20policy%2C%20financing%2C%20demand%20generation%2C%20and%20access%20to%20at-risk%20populations.%22%2C%22date%22%3A%222024-12-02%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.vaccine.2024.126483%22%2C%22ISSN%22%3A%220264-410X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0264410X24011654%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-10-30T00%3A11%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22QSU26UXL%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222024-09-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Kapandji%2C%20M.%2C%20Wada%2C%20A.%2C%20Yamamoto%2C%20K.%2C%20Dumre%2C%20S.%20P.%2C%20Nwe%2C%20K.%20M.%2C%20Lin%2C%20H.%2C%20Takamatsu%2C%20Y.%2C%20Thant%2C%20K.%20Z.%2C%20Thu%2C%20H.%20M.%2C%20Urano%2C%20T.%2C%20Pandey%2C%20B.%20D.%2C%20%26amp%3B%20Morita%2C%20K.%20%282024%29.%20Performance%20of%20Fujifilm%20Dengue%20NS1%20Antigen%20Rapid%20Diagnosis%20Kit%20Compared%20to%20Quantitative%20Real-Time%20Polymerase%20Chain%20Reaction.%20%3Ci%3EPathogens%3C%5C%2Fi%3E%2C%20%3Ci%3E13%3C%5C%2Fi%3E%289%29%2C%20818.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fpathogens13090818%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fpathogens13090818%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Performance%20of%20Fujifilm%20Dengue%20NS1%20Antigen%20Rapid%20Diagnosis%20Kit%20Compared%20to%20Quantitative%20Real-Time%20Polymerase%20Chain%20Reaction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Merveille%22%2C%22lastName%22%3A%22Kapandji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atsuhiko%22%2C%22lastName%22%3A%22Wada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ko%22%2C%22lastName%22%3A%22Yamamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shyam%20Prakash%22%2C%22lastName%22%3A%22Dumre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khine%20Mya%22%2C%22lastName%22%3A%22Nwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Htin%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyaw%20Zin%22%2C%22lastName%22%3A%22Thant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hlaing%20Myat%22%2C%22lastName%22%3A%22Thu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basu%20Dev%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Dengue%20is%20a%20viral%20infection%20caused%20by%20the%20dengue%20virus%20%28DENV%29%2C%20transmitted%20to%20humans%20through%20the%20bite%20of%20infected%20Aedes%20mosquitoes.%20About%20half%20of%20the%20world%5Cu2019s%20population%20is%20now%20at%20risk%20of%20dengue%2C%20which%20represents%20a%20global%20public%20health%20concern%2C%20especially%20in%20tropical%20and%20subtropical%20countries.%20Early%20detection%20of%20the%20viral%20infection%20is%20crucial%20to%20manage%20the%20disease%3B%20hence%2C%20effective%20rapid%20diagnostic%20tests%20are%20essential.%20In%20this%20study%2C%20we%20evaluated%20the%20performance%20between%20the%20new%20Fujifilm%20Dengue%20non-structural%20antigen%20diagnosis%20kit%20%28FF%20NS1%20kit%29%20and%20the%20SD%20Bioline%20NS1%20antigen%20test%20kit%20%28SD%20NS1%20kit%29%20against%20the%20quantitative%20real-time%20polymerase%20chain%20reaction%20%28qRT-PCR%29%20assays.%20The%20140%20acute%20serum%20samples%20collected%20from%20the%20Yangon%20General%20Hospital%20and%20Yangon%20Children%5Cu2019s%20Hospital%2C%20Myanmar%2C%20from%202017%20to%202019%20were%20characterised%20by%20the%20three%20assays.%20With%20the%20qRT-PCR%20as%20the%20standard%2C%20the%20FF%20NS1%20kit%20and%20the%20SD%20NS1%20kit%20exhibited%20sensitivity%20of%2094.3%25%20and%2088.6%25%2C%20respectively%2C%20and%20specificity%20of%20100%25%20in%20both%20kits.%20Moreover%2C%20the%20positivity%20rates%20of%20the%20FF%20NS1%20kit%20and%20the%20SD%20NS1%20kit%20were%2097.5%25%20and%2095%25%20in%20primary%20infection%20and%2090%25%20and%2080%25%20in%20secondary%20infection%2C%20respectively.%20Our%20overall%20results%20suggest%20that%20the%20FF%20NS1%20kit%20is%20reliable%20and%20accurate%20for%20detecting%20DENV%20infection.%22%2C%22date%22%3A%222024-09-23%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fpathogens13090818%22%2C%22ISSN%22%3A%222076-0817%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F2076-0817%5C%2F13%5C%2F9%5C%2F818%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-10-01T04%3A42%3A46Z%22%7D%7D%5D%7D
Mogasale, V. V., Sinha, A., John, J., Hasan Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Dhoubhadel, B. G., Edmunds, W. J., Clark, A., & Abbas, K. (2024). Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. BMJ Public Health, 2(2), e001089. https://doi.org/10.1136/bmjph-2024-001089
Mogasale, V. V., Sinha, A., John, J., Hasan Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Gopal Dhoubhadel, B., John Edmunds, W., Clark, A., & Abbas, K. (2024). Typhoid conjugate vaccine implementation in India: A review of supportive evidence. Vaccine: X, 21, 100568. https://doi.org/10.1016/j.jvacx.2024.100568
Shrestha, S., Bajracharya, M., Rimal, S., Bhujel, R., Chalise, B., Basaula, Y. N., Amatya, P., Pandey, S., Joshi, P., Adhikari, N., Ngwe Tun, M. M., Morita, K., Dumre, S. P., & Pandey, B. D. (2024). A challenge to clinical management: A case of expanded dengue syndrome co-infection with dengue 1 and dengue 3 serotypes in Nepal. Medical Reports, 8, 100123. https://doi.org/10.1016/j.hmedic.2024.100123
Maure, C., Khazhidinov, K., Kang, H., Auzenbergs, M., Moyersoen, P., Abbas, K., Santos, G. M. L., Medina, L. M. H., Wartel, T. A., Kim, J. H., Clemens, J., & Sahastrabuddhe, S. (2024). Chikungunya vaccine development, challenges, and pathway toward public health impact. Vaccine, 42(26), 126483. https://doi.org/10.1016/j.vaccine.2024.126483
Ngwe Tun, M. M., Kapandji, M., Wada, A., Yamamoto, K., Dumre, S. P., Nwe, K. M., Lin, H., Takamatsu, Y., Thant, K. Z., Thu, H. M., Urano, T., Pandey, B. D., & Morita, K. (2024). Performance of Fujifilm Dengue NS1 Antigen Rapid Diagnosis Kit Compared to Quantitative Real-Time Polymerase Chain Reaction. Pathogens, 13(9), 818. https://doi.org/10.3390/pathogens13090818